...
首页> 外文期刊>Acta biomaterialia >A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system.
【24h】

A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system.

机译:一种温度固化的可溶明胶微球基细胞载体,用于在水凝胶支架系统中递送软骨细胞。

获取原文
获取原文并翻译 | 示例

摘要

In this study, a novel therapeutic cell delivery methodology in the form of hydrogel encapsulating cell-laden microspheres was developed and investigated. As a model cell for cartilage tissue engineering, chondrocytes were successfully encapsulated in gelatin-based microspheres (mostly of diameter 50-100 μm, centred at 75-100 μm) with high cell viability during the formation of microspheres via a water-in-oil single emulsion process under a low temperature without any chemical treatment. These cell-laden microspheres were then encapsulated in alginate-based hydrogel constructs. By elevating the temperature to 37°C, the cell-laden microspheres were completely dissolved within 2 days, resulting in the same number of same-sized spherical cavities in hydrogel bulk, along with which the encapsulated cells were released from the microspheres and suspended inside the cavities to be cultivated for further development. In this cell delivery system, the microspheres played a dual role as both removable cell vehicles and porogens for creation of the intra-hydrogel cavities, in which the delivered cells were provided with both free living spaces and a better permeable environment. This temperature-cured dissolvable gelatin microsphere-based cell carrier (tDGMC) associating with cell-laden hydrogel scaffold was attempted and evaluated through WST-1, quantitative polymerase chain reaction, biochemical assays and various immunohistochemistry and histology stains. The results indicate that tDGMC technology can facilitate the delivery of chondrocytes, as a non-anchorage-dependent therapeutic cell, with significantly greater efficiency.
机译:在这项研究中,开发并研究了以水凝胶包裹载有细胞的微球形式的新型治疗性细胞递送方法。作为软骨组织工程的模型细胞,软骨细胞已成功地封装在基于明胶的微球中(大多数直径为50-100μm,中心为75-100μm),并且在油包水形成微球的过程中具有很高的细胞活力低温下的单乳液工艺,无需任何化学处理。然后将这些充满细胞的微球封装在基于藻酸盐的水凝胶构建物中。通过将温度升至37°C,充满细胞的微球在2天之内完全溶解,从而在水凝胶体积中产生相同数量的相同大小的球形腔,封装的细胞也随之从微球中释放出来并悬浮在内部为进一步发展而培育的空洞。在这种细胞递送系统中,微球体在可移动细胞媒介物和致孔剂中都扮演着双重角色,以产生水凝胶内腔,其中为被递送的细胞提供了自由的生存空间和更好的渗透环境。尝试并通过WST-1,定量聚合酶链反应,生化测定以及各种免疫组化和组织学染色法,尝试并评估了这种温度固化的可溶明胶微球基细胞载体(tDGMC)与细胞载水凝胶支架的关联。结果表明,tDGMC技术可以促进软骨细胞作为非锚定依赖性治疗细胞的传递,其效率显着提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号